Quince Therapeutics, Inc. (QNCX) insider trading

{
  "status": "OK",
  "results": [
    {
      "tickers": [
        "QNCX"
      ],
      "issuer_cik": "0001662774",
      "owner_cik": "0001613842",
      "accession_number": "0000912282-25-001469",
      "form_type": "4",
      "filing_date": "2025-12-29",
      "period_of_report": "2025-12-26",
      "issuer_name": "Quince Therapeutics, Inc.",
      "issuer_trading_symbol": "QNCX",
      "owner_name": "Benatti Luca",
      "is_director": true,
      "is_officer": false,
      "is_ten_percent_owner": false,
      "is_other": false,
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": false,
      "transaction_date": "2025-12-26",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 50000,
      "transaction_price_per_share": 3.47,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 39179,
      "transaction_value": 173500,
      "direct_or_indirect": "D",
      "footnotes": [
        {
          "id": "F1",
          "description": "The sale price reported above is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.45 to $3.56, inclusive. The reporting person undertakes to provide to Quince Therapeutics, Inc., any security holder of Quince Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."
        }
      ]
    }
  ]
}

// trimmed to 1 results

The response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.